A potential new treatment in development for multiple sclerosis created at QIMR Berghofer Medical Research Institute has secured a deal worth up to $63 million.
-
Latest News US company acquires share of royalties in QIMR Berghofer's potential multiple sclerosis treatmen December 16, 2021
-
Latest News Carina Biotech licenses German technology for CAR-T December 16, 2021Cell therapy immuno-oncology company Carina Biotech has announced a new worldwide, exclusive license agreement with Bayerische Patentallianz for the CXCR6-transduced CAR-T cell technology.
-
Latest News Recce Pharmaceuticals recruits first cohort in new study December 16, 2021Synthetic anti-infectives company Recce Pharmaceuticals (ASX:RCE) has announced it has recruited the first cohort of 10 healthy male subjects in its Phase I intravenous clinical trial of its lead compound.
-
Latest News Immutep advances IMP761 manufacturing with new agreement December 16, 2021Immunotherapy development company Immutep (ASX:IMM) has signed a Manufacturing Service Agreement with Northway Biotech.
-
Latest News Starpharma announces early orders following Vietnam distribution agreement December 14, 2021Starpharma (ASX:SPL) has signed a commercial arrangement for its antiviral nasal spray Viraleze in Vietnam with orders in excess of 2 million since late October.
-
AusBiotech Stem cell advocacy highly commended December 14, 2021Research Australia’s 18th Health and Medical Research Awards have been announced, and AusBiotech congratulates Professor Megan Munsie, Melbourne University, who was recognised for her ongoing advocacy work in stem cells.
-
Latest News Agtech company Bio-Gene Technology completes capital raise December 14, 2021Agtech development company Bio-Gene Technology (ASX: BGT) announced it has secured commitments to raise $3.2 million through a strategic share placement to sophisticated and professional investors.
-
Latest News Servatus completes capital raise to progress projects December 13, 2021Unlisted Australian company Servatus has announced it has secured $7.5 million in an oversubscribed capital raise.
-
Latest News Chimeric announces planned key management changes December 14, 2021Chimeric Therapeutics (ASX:CHM) has announced several planned changes to key management roles for 2022.
-
Latest News Telix in-licences novel tumour microenvironment PET Tracer December 8, 2021Telix Pharmaceuticals (ASX:TLX) has announced an exclusive licence agreement for a novel positron emission tomography radiotracer originating from the Université catholique de Louvain in Belgium.
-
AusBiotech Save the date: NSW Women in Life Sciences Luncheon announced December 9, 2021AusBiotech and Medicines Australia are thrilled to announce the annual NSW Women in Life Sciences Luncheon will be held in Sydney on Friday, 11 March 2022 in celebration of International Women’s Day, on 8 March.
-
Latest News Change in leadership for Cochlear North America December 8, 2021Cochlear has announced that Lisa Aubert will succeed the retiring Tony Manna as the president of its North American operation.
-
Latest News Recce Pharmaceuticals update on clinical trial of burn wound infections December 8, 2021Synthetic anti-infective company Recce Pharmaceuticals (ASX:RCE) has provided an update on its Phase I/II clinical trial for the treatment of burn wound infections.
-
ResApp Health establishes COVID-19 scientific advisory board December 8, 2021Digital health company ResApp Health (ASX:RAP) has announced the establishment of a COVID-19 Scientific Advisory Board.
-
Latest News Emyria announces positive initial MDMA-analogue screening and patent lodgement December 8, 2021Emyria (ASX:EMD) says positive results have been received for the first batch of MDMA-analogues screened for neuroreceptor activity with the pharmaceutical development company, Eurofins.
-
Latest News Positive late-stage trial results for Neuren Pharmaceuticals' trofinetide December 7, 2021Neuren Pharmaceuticals (ASX:NEU) has reported that its partner for trofinetide in North America, Acadia Pharmaceuticals, has announced positive top-line results from a Phase 3 study.
-
2021 Brilliant Women in Digital Health December 7, 2021AusBiotech congratulates Kate Quirke, CEO of Alcidion, who has been awarded a winner of the inaugural 2021 Brilliant Women in Digital Health.
-
Latest News 'Australians should be the first in the world to access new medical technologies' December 7, 2021A new report commissioned by Johnson & Johnson says Australia's framework for approving and funding new medical technologies must evolve to ensure it meets the needs of patients.
New Stories
-
Uniting to progress biotech in the year ahead
December 16, 2021 - - AusBiotech -
Australia’s health security audit closing with the year
December 16, 2021 - - AusBiotech -
CSL completes $6.3 billion placement to support Vifor acquisition
December 16, 2021 - - Latest News -
Recce Pharmaceuticals recruits first cohort in new study
December 16, 2021 - - Latest News -
US company acquires share of royalties in QIMR Berghofer's potential multiple sclerosis treatmen
December 16, 2021 - - Latest News -
Carina Biotech licenses German technology for CAR-T
December 16, 2021 - - Latest News -
Immutep advances IMP761 manufacturing with new agreement
December 16, 2021 - - Latest News